We are at a crucial moment in history. The effects of climate change are undeniable, and agriculture is tied to more than 10% of greenhouse gas emissions in the U.S. alone. Farmers are of course inherently committed to conservation – after all, few businesses are as dependent on natural resources. But to sustainably address the changing environment while growing enough to keep up with a rapidly growing global population, farmers also need new technology and tools.

There is no silver bullet to solve the climate crisis. However, the recent confluence of major technological advances offers society a unique opportunity to take a major leap forward in improving the resilience and sustainability of our global food system.

This change starts with seed – seed that requires fewer natural resources while continuing to produce enough food and feed. The key is an approach called multiplex gene editing, a new and powerful breeding technique with the potential to meaningfully change how plants grow and have a nature-positive impact on the planet.

Download our free white paper for a better understanding of multiplex gene editing, how it compares to existing breeding technologies, and its ability to help unlock the full potential of seed – and the future of agriculture.


Unlocking seed potential for greater yield with fewer resources
Now in its third edition, the Credit Suisse Cleantech Innovation Whitepaper focuses on innovative companies and industries that are accelerating technology and infrastructure to tackle climate change. For the latest report, CFO Stuart Brown sat down to discuss how Inari is using nature-positive design to create seeds that serve the population, the planet, and the people who grow our food.

Stuart Brown

Chief Financial Officer


Five Perspectives on 10 Years of CRISPR
What we do at Inari would not be possible without CRISPR. Our SEEDesign™ platform with our efforts to bring nature-positive outcomes to the global food system literally demands it. To help us reflect on this momentous anniversary, we asked some of our colleagues who regularly use CRISPR to convey what the technology has meant in its first 10 years – and where it could take us next. Here’s what they had to say.